Not applicableUnknownNCT03907670What this trial is testingChronic Myloid Leukemic Patients Treated With Tyrosine Kinase InhibitorWho this might be right forChronic Phase Chronic Myelogenous Leukemia Assiut University 45
Post-approval studies (Phase 4)UnknownNCT04677439What this trial is testingFlumatinib in CML-CP Patients With Ph+ Post Imatinib FailureWho this might be right forFlumatinibChronic Myeloid Leukemia, Chronic PhaseImatinib Shenzhen Second People's Hospital 200
Large-scale testing (Phase 3)Ended earlyNCT03746054What this trial is testingEvaluation of a Cardiovascular Active Prevention in Chronic Myeloid Leukemia on the Cardiovascular Morbi-mortalityWho this might be right forChronic Myeloid Leukemia (CML) University Hospital, Angers 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT03817398What this trial is testingStopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid LeukemiaWho this might be right forChronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Children's Oncology Group 110
Testing effectiveness (Phase 2)Study completedNCT00089037What this trial is testingSirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantationWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00008164What this trial is testingUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaWho this might be right forChildhood Langerhans Cell HistiocytosisLeukemiaLymphoma+3 more Herbert Irving Comprehensive Cancer Center 30
Early research (Phase 1)Temporarily pausedNCT05400122What this trial is testingNatural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in CancerWho this might be right forColorectal CancerHematologic MalignancyRectum Cancer+15 more David Wald 12
Testing effectiveness (Phase 2)WithdrawnNCT00301912What this trial is testingBusulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAnemiaChronic Myeloproliferative DisordersLeukemia+4 more University of California, San Francisco
Testing effectiveness (Phase 2)Study completedNCT00245037What this trial is testingBusulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more OHSU Knight Cancer Institute 147
Early research (Phase 1)Study completedNCT02253277What this trial is testingSafety and Tolerability of Combined Treatment With Nilotinib and Ruxolitinib in CML and Ph+ ALL PatientsWho this might be right forChronic Myeloid Leukemia Novartis Pharmaceuticals 5
Testing effectiveness (Phase 2)Study completedNCT00217386What this trial is testingAnti-Thymocyte Globulin and Etanercept in Treating Patients With Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases Fred Hutchinson Cancer Center 30
Early research (Phase 1)Study completedNCT00073944What this trial is testingBCX-1777 in Treating Patients With Refractory CancerWho this might be right forCancer BioCryst Pharmaceuticals
Not applicableLooking for participantsNCT06390306What this trial is testingThe Efficacy and Safety of Third-generation TKIs Combined With Azacitidine and Bcl-2 Inhibitor in Patients With CML-MBPWho this might be right forChronic Myeloid Leukemia Peking University People's Hospital 30
Not applicableStudy completedNCT00951626What this trial is testingA Standardized Nursing Intervention Protocol for HCT PatientsWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+5 more City of Hope Medical Center 282
Not applicableWithdrawnNCT00898612What this trial is testingEarly Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow TransplantWho this might be right forLymphoma Mayo Clinic
Not applicableStudy completedNCT04048564What this trial is testingObservational Study on CML Patients in Any Phase of the Disease Treated With Ponatinib (Iclusig®)Who this might be right forChronic Myeloid Leukemia Incyte BioSciences France 120
Testing effectiveness (Phase 2)Ended earlyNCT01357655What this trial is testingPhase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)Who this might be right forLeukemia Bristol-Myers Squibb 70
Post-approval studies (Phase 4)UnknownNCT04933526What this trial is testingThe Efficacy and Safety of Switching to Flumatinib Versus Dasatinib After Imatinib-related Low-grade Adverse Events in CML-CP PatientsWho this might be right forChronic Myeloid Leukemia in Chronic Phase Shenzhen Second People's Hospital 118
Testing effectiveness (Phase 2)WithdrawnNCT02115672What this trial is testingImatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous LeukemiaWho this might be right forChronic Myeloid Leukemia Sheba Medical Center
Testing effectiveness (Phase 2)Study completedNCT04188405What this trial is testingDecitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous LeukemiaWho this might be right forAccelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Myeloid LeukemiaBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive+4 more M.D. Anderson Cancer Center 20